Tags

Type your tag names separated by a space and hit enter

[Prevention and treatment of fluctuations in patients with Parkinson's disease].
Praxis (Bern 1994). 2006 Dec 20; 95(51-52):2013-8.P

Abstract

Fluctuations (wearing-off, on off phenomenon, dyskinesias) are a big challenge in the long term treatment of parkinsonian patients. We describe the current strategies for prevention and treatment of fluctuations. Special emphasis is put on two new methods which will soon be available. The new dopamine agonist Rotigotine (Neupro) can be transdermally applied. This is a rather simple way to achieve a continuous dopaminergic stimulation. The same goal is achieved by direct application of levodopa-/carbidopa-gelsuspension (Duodopa) in the duodenum by the help of an electronic pump.

Authors+Show Affiliations

Neurologische Praxis, St. Gallen hpludin@hin.chNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

17294589

Citation

Ludin, H P., and Ch Surber. "[Prevention and Treatment of Fluctuations in Patients With Parkinson's Disease]." Praxis, vol. 95, no. 51-52, 2006, pp. 2013-8.
Ludin HP, Surber Ch. [Prevention and treatment of fluctuations in patients with Parkinson's disease]. Praxis (Bern 1994). 2006;95(51-52):2013-8.
Ludin, H. P., & Surber, C. h. (2006). [Prevention and treatment of fluctuations in patients with Parkinson's disease]. Praxis, 95(51-52), 2013-8.
Ludin HP, Surber Ch. [Prevention and Treatment of Fluctuations in Patients With Parkinson's Disease]. Praxis (Bern 1994). 2006 Dec 20;95(51-52):2013-8. PubMed PMID: 17294589.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Prevention and treatment of fluctuations in patients with Parkinson's disease]. AU - Ludin,H P, AU - Surber,Ch, PY - 2007/2/14/pubmed PY - 2007/3/21/medline PY - 2007/2/14/entrez SP - 2013 EP - 8 JF - Praxis JO - Praxis (Bern 1994) VL - 95 IS - 51-52 N2 - Fluctuations (wearing-off, on off phenomenon, dyskinesias) are a big challenge in the long term treatment of parkinsonian patients. We describe the current strategies for prevention and treatment of fluctuations. Special emphasis is put on two new methods which will soon be available. The new dopamine agonist Rotigotine (Neupro) can be transdermally applied. This is a rather simple way to achieve a continuous dopaminergic stimulation. The same goal is achieved by direct application of levodopa-/carbidopa-gelsuspension (Duodopa) in the duodenum by the help of an electronic pump. SN - 1661-8157 UR - https://www.unboundmedicine.com/medline/citation/17294589/[Prevention_and_treatment_of_fluctuations_in_patients_with_Parkinson's_disease]_ L2 - https://econtent.hogrefe.com/doi/10.1024/1661-8157.95.51.2013?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -